Summary statement: An easy-to-implement protein degradation method that targets GFP fusions eliminates proteins in specific C. elegans tissues.
INTRODUCTION
Techniques for disrupting protein function in specific tissues or at particular points in development are enabling detailed analysis of developmental mechanisms. To analyze gene function in specific tissues, Cre-LoxP based knockout methods have been established in many model organisms, including C. elegans (Ruijtenberg and Van Den Heuvel, 2015) . Tissue-specific CRISPR-Cas9 based gene knockouts and RNAi have also been described in C. elegans (Qadota et al., 2007; Shen et al., 2014) . However, the utility of DNA/RNA editing approaches can be limited by perdurance of the target protein following excision, which can delay the manifestation of phenotypes.
An alternative approach that circumvents this problem is to directly target proteins for degradation in specific tissues. One method for achieving this is based on transplanting the auxin-induced protein degradation system from plants (Holland et al., 2012; Nishimura et al., 2009) . In this system, addition of the small molecule auxin activates a plant-specific F-box protein, TIR1, that serves as a substrate recognition component of an Skp1-Cullin-F-box (SCF) E3 ubiquitin ligase. Active TIR1 targets proteins containing a specific degron sequence. The auxin-inducible degron (AID) system was recently adapted for C. elegans (Zhang et al., 2015) . However, it would be useful to have a robust genetically-encoded method that does not require a small molecule, as the exposure kinetics and dosage of small molecules in C. elegans is limited by barriers such as the cuticle and the eggshell. To this end, a method was developed that takes advantage of an endogenous C. elegans protein degradation system. In this approach, target proteins are tagged with a short degron sequence (ZF1), and the SOCS-box adaptor protein ZIF-1, which targets ZF1-containing proteins for proteasomal degradation, is expressed in the target tissue (Armenti et al., 2014) .
However, a limitation of this system is that ZIF-1 plays an essential role during early embryogenesis (DeRenzo et al., 2003; Reese et al., 2000) . Thus, proteins tagged with the ZF1 degron are degraded during embryogenesis as well as in the target tissue, which is problematic for analysis of proteins that function during embryogenesis as well as at later developmental stages.
Here, we develop a new system that combines potent ZIF-1-mediated protein degradation (Armenti et al., 2014) with the previously described deGradFP approach (Caussinus et al., 2012) . In deGradFP, a GFP nanobody is fused to a F-box protein to degrade GFP-tagged proteins. Since the originally described F-box adaptor does not work in C. elegans (our unpublished observations), we fused the GFP nanobody to ZIF-1. We show that expression of this fusion enables efficient depletion of GFP-tagged proteins in multiple tissues. In conjunction with GFP-tagging at endogenous loci using CRISPR-Cas9 (Paix et al., 2016) or rescue of null mutants with GFP fusions expressed from transgenes, this approach enables routine protein depletion controlled by the spatial and temporal expression pattern of the promoter driving the GFP-degrading module. We describe a toolkit of transgenes expressing GFP degradation adaptors in different tissues that should facilitate tissue-specific analysis of protein function in C.
elegans.

RESULTS
Epidermal expression of a GFP nanobody::ZIF-1 fusion depletes GFP-tagged proteins that localize to different subcellular locations
To selectively degrade GFP-tagged proteins, we expressed a GFP nanobody::ZIF-1 fusion under tissue-specific promoters (Fig. 1A) . This fusion protein acts as a GFP-to-ligase adapter that promotes ubiquitination of the GFP-tagged protein by the Cul2 family E3 ligase CUL-2 and subsequent degradation by the proteasome (DeRenzo et al., 2003) . We previously showed that epidermis-specific expression of a GFP nanobody::ZIF-1 fusion (epiDEG; GFP::MAD-1, 81%; GFP::β-tubulin, 58%; Fig. 1B-D) , whereas signal intensity was unchanged in control tissues ( Fig. 1C-D ; DLG-1::GFP & GFP::MAD-1, GFP::β-tubulin was expressed in the epidermis only). We conclude that the GFP nanobody::ZIF-1 fusion can degrade proteins that localize to different subcellular locations; we note that it remains unclear whether depletion of proteins from the nucleus and cellular junctions occurs by targeting and degradation at these locations or by degrading the protein from the cytoplasm. With the exception of GFP::β-tubulin, which we expect is heavily expressed, reduction by epiDEG was consistently greater than 80% ( Fig. 1C-D ; Wang et al., 2015) .
GFP-mediated protein degradation is efficient in multiple C. elegans tissues
To determine whether the GFP nanobody::ZIF-1 fusion could degrade GFPtagged proteins in different tissues, we expressed the GFP nanobody::ZIF-1 fusion or ZIF-1 alone (as a control) using promoters that drive expression in the intestine (intDEG, Pelt-2; Fukushige et al., 1998), body wall muscle (bwmDEG, Pmyo-3; Fire and Waterston, 1989) and sensory neurons (senNeuDEG, Posm-6; Collet et al., 1998) . The transgenes also included an operon linker (Huang et al., 2001) followed by an mCherry::Histone H2b reporter to allow identification of cells expressing the degradation module (DEG) or control transgenes ( Fig. 2A) . To assess the relative function of the degradation module in different tissues, the transgenes were introduced into a background expressing endogenously tagged GFP::MAD-1, which is widely expressed and localizes to nuclei in differentiated tissues throughout development (Fig. S2) . In all three tested tissues, GFP::MAD-1 signal was eliminated when the GFP nanobody::ZIF-1 fusion, but not ZIF-1 alone, was expressed (Fig. 2B-D) . Testing intDEG with a second endogenously tagged transgene GFP::PP1 GSP-2 also revealed specific reduction of the intestinal signal to background levels (Fig. S3) . We conclude that the GFP nanobody::ZIF-1 fusion targets GFP-tagged proteins for degradation in multiple tissues (promoters and targets are summarized in Table S1 ).
Degradation of GIP-2::GFP in the intestine causes cell division defects and impairs C. elegans growth
To determine whether GFP-mediated degradation recapitulated loss-of-function phenotypes, we analyzed embryonic and larval phenotypes in control and intDEG worms crossed with endogenously tagged GIP-2::GFP, an essential component of the microtubule-nucleating γ-tubulin complex. During C. elegans intestinal differentiation in the embryo, the γ-tubulin complex re-localizes from centrosomes to the apical cell surface (Feldman and Priess, 2012; Fig. 3A) . Co-expressing intDEG, but not the control transgene, eliminated the intestinal GIP-2::GFP signal (Fig. 3A) .
The C. elegans intestine arises from the E blastomere of the 8-cell embryo (Fig. 3A) ; larval intDEG worms also grew more slowly and reached a smaller adult size than controls (Fig. 3B) . Thus, intestinal GIP-2::GFP degradation resulted in a tissue-specific cell division defect consistent with loss of the γ-tubulin complex, validating our approach.
Degradation of GFP::DLK-1 in the touch neurons blocks axon regeneration
To determine whether GFP-mediated protein degradation occurs in the nervous system, we expressed the GFP nanobody::ZIF-1 fusion from a transgene that also included cytoplasmic mKate2 (to visualize axons) using the mec-18 promoter (tchNeuDEG; Fig. 4A ). To assess efficacy we targeted a GFP fusion with DLK-1 (DualLeucine zipper Kinase MAPKKK) (K. Noma and Y. Jin, unpublished), which is required to initiate axon regeneration (Hammarlund et al., 2009; Yan et al., 2009) . Following laser-induced axotomy in the PLM touch neuron (Fig. 4B) , GFP::DLK-1 promoted axon regrowth in the presence of endogenous DLK-1, consistent with the known effects of DLK-1 overexpression (Hammarlund et al., 2009; Yan et al., 2009) , while a dlk-1 deletion mutant strongly impaired regrowth (Fig. 4C,D) . GFP::DLK-1 expression fully rescued the impaired regrowth of the dlk-1Δ mutant, and this rescue was abolished by introduction of tchNeuDEG ( Fig. 4C-E) . We note that no defects in axon regrowth were detected in tchNeuDEG worms with endogenously tagged GIP-2::GFP or DHC-1::GFP (Fig. S4), suggesting that GIP-2 and DHC-1 are not required for axon regrowth in PLM touch neurons.
DISCUSSION
We describe a robust method for the degradation of GFP fusions that we anticipate will complement existing approaches-genetic locus removal, RNA interference and auxin-mediated degradation-to enable tissue-specific analysis of protein function in C. elegans. The utility of this approach is enhanced by the recent development of CRISPR/Cas9-based methods that enable routine GFP tagging of endogenous loci (Dickinson et al., 2013; Paix et al., 2016) . We expect that the set of strains we describe here will be a useful resource and will serve as a template for engineering of additional versions that will expand the utility of this strategy.
The strength of the promoter driving the degron cassette, the efficiency of CUL-2-dependent proteasomal degradation in the target tissue, and the expression level of the target will influence the kinetics and penetrance of degradation. At present, we do not know the precise kinetics of in vivo degradation. When the ZF1 degron and ZIF-1 pair was used, target degradation occurred with a half-life of 20-30 minutes (Armenti et al., 2014) . We expect the GFP nanobody::ZIF-1 fusion to have comparable performance, but degradation kinetics will need to be measured for each degron/target pair when this information is important for interpreting the phenotype. Whether including sequences targeting the GFP nanobody::ZIF-1 fusion to specific compartments (e.g. the nucleus)
would improve degradation efficiency in that compartment also remains to be tested.
The GFP nanobody we use here ( 
